mynth
09/2025

INLOG acquired by GENII SOFTWARE GROUP

FRANCE Software / Industry-Specific Software / Healthcare EV €50–150M

Context

Private equity firm Abenex, alongside the management team, has successfully completed the divestiture of healthcare software publisher Inlog to Munich-based GENII Software Group. Orchestrated by investment bank Lincoln International, the transaction marks the exit of Abenex following a successful transformation period. The acquirer, GENII Software Group, is majority-backed by private equity sponsor Bregal Unternehmerkapital, with additional support from Elvaston. For the acquirer GENII Software Group, the buyout significantly strengthens its Laboratories division and consolidates its position as a leading European provider of specialized enterprise software. During Abenex's ownership tenure, Inlog doubled its revenues, completed three strategic acquisitions, and expanded its footprint into Germany and the Benelux region. Partnering with GENII will provide Inlog with the necessary scale and resources to accelerate international revenue growth and drive product innovation, particularly focusing on AI and cloud-based technologies.

It is worth noting that the fund Abenex took control of Inlog through an LBO in 2020.

INLOG, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the TMT (Tech, Media, Telecom) sector (14.7x).

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Inlog is a software editor for the healthcare sector, specializing in blood product traceability and laboratory management. Founded after its spin-off from the American Haemonetics Corporation, Inlog has structured its teams and now has 80 employees worldwide. The company opened a subsidiary in Germany in 2022 and generates nearly 20% of its revenue internationally. Inlog offers innovative solutions for healthcare systems and has made several acquisitions, including the French companies Ubilab and Viskali, as well as the Belgian company Moonchase.

Ent. Value

€50–150M

Equity Value

[members only]

Multiples

EV / Revenue

4x–10x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
€5–25M
€5–25M
[members only]
2023
€5–25M
€5–25M
[members only]

Other operations with INLOG

Other operations with INLOG

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
09/2020ABENEXINLOGFRANCEHealthcare

REFERENCES

Valuation range: EV €50–150M

Revenue range: €5–25M

EBITDA range: €5–25M

EV/Revenue range: 4x - 10x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INLOG by GENII SOFTWARE GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: inlog

Acquirer: genii software group